Find trials
Search tips

ICCaRE For Black Men Consortium Biospecimen Resource Core

Overview

About this study

The purpose of ths study is to eliminate the disproportionate burden of prostate cancer (CaP) disparities experienced by black men globally. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

 Inclusion Criteria:

  • Black males, aged 21-85 with abnormal clinical prostate tests and/or a history of prostate cancer diagnosis.

  • Describe provisions for inclusion of minorities: The consortium is solely intended to include Black men due to the disproportionate disparities experienced by BM globally.  

Exclusion Criteria: 

  • < 21 and > 85. 

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 8/3/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Contact us for the latest status

Contact information:

Emelina Asto-Flores

9049537099

asto-flores.emelina@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20611704

Mayo Clinic Footer